ArticleClinical reviews in allergy & immunology2007

Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection.

Tobias Warger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.